CLOs on the Move

Oppenheimer

www.opco.com

 
Oppenheimer and Co. Inc. ("Oppenheimer") is a leading investment bank and full-service investment firm that provides financial services and advice to high net worth investors, individuals, businesses and institutions. For over 130 years, we have provided investors with the necessary expertise and insight to meet the challenge of achieving their financial goals. Our commitment to our clients` investment needs, our experienced and dedicated professionals, and our proud tradition empower us to deliver effective and innovative solutions to our clients. Oppenheimer is a wholly owned subsidiary of Oppenheimer Holdings Inc., an integrated financial services holdings company. Oppenheimer Holdings Inc.`s other wholly owned ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $500M-1 Billion
  • www.opco.com
  • 85 Broad Street
    New York, NY USA 10004
  • Phone: 212.668.8000

Executives

Name Title Contact Details
Dominic Valentino
Chief Compliance Officer Profile

Similar Companies

DOUGLAS CAPITAL MANAGEMENT

We are driven not only by years of experience, but by disciplined planning, attentive insight and analytical capabilities.

Salida Capital LP

Salida Capital LP is a Toronto, ON-based company in the Financial Services sector.

NCP investmentbanking

NCP investmentbanking is a Des Moines, IA-based company in the Financial Services sector.

Legend Holdings Inc

Legend Holdings Inc is a Bellevue, WA-based company in the Financial Services sector.

BullFrog AI

BullFrog AI is an investor-backed company determined to become the undisputed leader in precision medicine. Our mission is to find the link between therapies and patients, and improve their lives. Using our proprietary technology platform, we aim to predict which patients will benefit from which medications, effectively improving clinical outcomes and eliminating the problem of trial-and-error prescriptions. We have an exceptional team of life science industry leaders, AI technologists, scientists, physicians and advisors determined to help BullFrog AI revolutionize drug development. Through our partnership with one of the most prestigious research institutions in the world, we take pride in technology innovation by staying on the cutting edge of AI.